Status:
UNKNOWN
Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix.
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Conditions:
Prostate Cancer
Erectile Dysfunction
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the use of a hemostatic gelatine-thrombin matrix during athermal nerve-sparing prostate resection compared to conventional hemostasis using electrocautery in p...
Eligibility Criteria
Inclusion
- Patient age \>18
- Histologically proven prostate cancer ( Gleason \<8; PSA\<10ng/ml)
- Disease confined to prostate in clinical examination
- Preoperative IEEF-5-Score\>20
- Patient is able to give informed consent
Exclusion
- ASA IV-V
- Prior extensive abdominal surgery
- Signs for metastatic disease
- Known allergy against bovine material
- Patient is unable to give informed consent
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2014
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01448798
Start Date
October 1 2011
End Date
January 1 2014
Last Update
October 7 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johann Wolfgang Goethe University Hospital
Frankfurt/M., Germany, 60590